Cancer cells often exhibit dysregulated signal transduction pathways, leading to uncontrolled cell proliferation and survival. Signaling proteins in these pathways can be allosterically regulated, making them potential targets for cancer therapy. Understanding allosteric regulation can aid in designing drugs that specifically target these dysregulated pathways.
